First Treatment in 30 Years for Rare Disease Safe, Effective
Subcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments.
Source: medscape.com
Page 18 - Eigg News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eigg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eigg Today - Breaking & Trending Today
In Myasthenia Gravis, Antibodies Pass Open-Label Tests
Researchers presented data from an open-label extension study following the phase 3 MycarinG trial of rozanolixizumab and the ADAPT-SC+ study of efgartigimod.
Source: medscape.com
Anniversary ceilidh to bring curtain down on Fèis Lochabair's 30th year
Lochabar Ceilidh Trail 2023, Ruairidh Fothergill, Niall MacDonald, Floraidh Stevenson and Annie MacNeil.
Source: obantimes.co.uk
IGG reveals the most sought after pension manager skills
Employers look for a wide variety of skills in pension managers, a report from Independent Governance Group (IGG) has found.
Source: professionalpensions.com
Antiphospholipid Antibodies Vary by Race in People With SLE
A study of multiple cohorts of patients with systemic lupus erythematosus showed significantly lower prevalence of antiphospholipid antibodies (aPLs) among Black patients.
Source: medscape.com